Programming apoptosis and autophagy with novel approaches for diabetes mellitus

Current Neurovascular Research

Volumn 12, Issue 2, 2015, Pages 173-188

  Maiese, Kenneth ^a  

^a Laboratory of Cellular and Molecular Signaling   (United States)

Author keywords

AMPK; Apoptosis; Autophagy; Cardiac; CCN; Diabetes mellitus; Erythropoietin; Forkhead; FoxO; Metformin; MTOR; Nervous system; Oxidative stress; SIRT1; Sirtuins; Stem cells; Vascular; WISP1; Wnt

Indexed keywords

HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; MAMMALIAN TARGET OF RAPAMYCIN; METFORMIN; SIRTUIN 1; UNCLASSIFIED DRUG; UNCOUPLING PROTEIN; WNT1 INDUCIBLE SIGNALING PATHWAY PROTEIN 1; WNT1 PROTEIN;

APOPTOSIS; ARTICLE; AUTOPHAGY; CAUSE OF DEATH; CELL AGING; CELL DIFFERENTIATION; CELL FATE; CELL METABOLISM; CELL PROLIFERATION; DIABETES MELLITUS; ENDOPLASMIC RETICULUM STRESS; ENDOTHELIAL PROGENITOR CELL; ENDOTHELIUM CELL; GLUCOSE HOMEOSTASIS; HUMAN; INSULIN RESISTANCE; OXIDATIVE STRESS; PRIORITY JOURNAL; WNT SIGNALING PATHWAY; WORLD HEALTH ORGANIZATION; ANIMAL;

ANIMALS; APOPTOSIS; AUTOPHAGY; DIABETES MELLITUS; HUMANS;

EID: 84930665946     PISSN: 15672026     EISSN: 18755739     Source Type: Journal    
DOI: 10.2174/1567202612666150305110929     Document Type: Article

References (305)

1. Centers for Medicare and Medicaid Services. National Health Expenditure Projections 2012-2022. wwwcmsgov. 2013.
2. Jia G, Aroor AR, Martinez-Lemus LA, Sowers JR. Invited Review: Over-nutrition, mTOR Signaling and Cardiovascular Diseases. Am J Physiol Regul Integr Comp Physiol. 2014 Sep 24.
3. Maiese K, Chong ZZ, Shang YC, Hou J. Novel Avenues of Drug Discovery and Biomarkers for Diabetes Mellitus. J Clin Pharmacol 2011 Mar 10;51(2):128-52.
4. Maiese K, Chong ZZ, Shang YC, Wang S. Novel directions for diabetes mellitus drug discovery. Expert Opin Drug Discov 2013 Jan;8(1):35-48.
5. Rutter MK, Massaro JM, Hoffmann U, O'Donnell CJ, Fox CS. Fasting Glucose, Obesity, and Coronary Artery Calcification in Community-Based People Without Diabetes. Diabetes Care 2012 Jul 6.
6. Xu E, Schwab M, Marette A. Role of protein tyrosine phosphatases in the modulation of insulin signaling and their implication in the pathogenesis of obesity-linked insulin resistance. Rev Endocr Metab Disord 2014 Mar;15(1):79-97.
7. Himmetoglu S, Teksoz S, Zengin K, Yesim T, Taskin M, Dincer Y. Serum levels of fetuin A and 8-hydroxydeoxyguanosine in morbidly obese subjects. Exp Clin Endocrinol Diabetes 2013 Aug;121(8):505-8.
8. Liu Y, Palanivel R, Rai E, et al. Adiponectin stimulates autophagy and reduces oxidative stress to enhance insulin sensitivity during high fat diet feeding in mice. Diabetes. 2014 Jul 28;64(1):36-48.
9. Shao S, Yang Y, Yuan G, Zhang M, Yu X. Signaling molecules involved in lipid-induced pancreatic Beta-cell dysfunction. Dna Cell Biol. 2013 Feb;32(2):41-9.
10. Essser N, Paquot N, Scheen AJ. Anti-inflammatory agents to treat or prevent type 2 diabetes, metabolic syndrome and cardiovascular disease. Expert Opin Invest Drugs 2014 Oct 25:1-25.
11. Maiese K, Chong ZZ, Shang YC, Wang S. Erythropoietin: new directions for the nervous system. Int J Mol Sci 2012;13(9):11102-29.
12. Maiese K, Li F, Chong ZZ. New avenues of exploration for erythropoietin. Jama 2005 Jan 5;293(1):90-5.
13. White MF. IRS2 integrates insulin/IGF1 signalling with metabolism, neurodegeneration and longevity. Diabetes Obes Metab 2014 Sep;16 Suppl 1:4-15.
14. Zhang Y, Wang L, Dey S, et al. Erythropoietin action in stress response, tissue maintenance and metabolism. International journal of molecular sciences. 2014;15(6):10296-333.
15. Chong ZZ, Maiese K. The Src homology 2 domain tyrosine phosphatases SHP-1 and SHP-2: diversified control of cell growth, inflammation, and injury. Histol Histopathol. 2007 Nov;22(11):1251-67.
16. Abdullah A, Wolfe R, Mannan H, Stoelwinder JU, Stevenson C, Peeters A. Epidemiologic Merit of Obese-Years, the Combination of Degree and Duration of Obesity. Am J Epidemiol. 2012 Jun 28.
17. World Health Organization. Global status report on noncommunicable diseases 2010. Geneva. 2011.
18. . National Diabetes Statistics Report: Estimates of Diabetes and Its Burden in the United States,. US Department of Health and Human Services. 2014;Atlanta, GA.
19. Maiese K. Diabetic stress: new triumphs and challenges to maintain vascular longevity. Expert Rev Cardiovasc Ther. 2008 Mar;6(3):281-4.
20. Harris MI, Eastman RC. Early detection of undiagnosed diabetes mellitus: A US perspective. Diabetes Metab Res Rev. 2000 Jul-Aug;16(4):230-6.
21. Maiese K, Chong ZZ, Wang S, Shang YC. Oxidant Stress and Signal Transduction in the Nervous System with the PI 3-K, Akt, and mTOR Cascade. Int J Mol Sci 2013;13(11):13830-66.
22. Maiese K, Chong ZZ, Shang YC. Mechanistic insights into diabetes mellitus and oxidative stress. Curr Med Chem 2007;14(16):1729-38.
23. Maiese K, Shang YC, Chong ZZ, Hou J. Diabetes mellitus: channeling care through cellular discovery. Curr Neurovasc Res. 2010 Feb 1;7(1):59-64.
24. Alexandru N, Popov D, Georgescu A. Platelet dysfunction in vascular pathologies and how can it be treated. Thromb Res 2012 Feb;129(2):116-26.
25. Arunachalam G, Samuel SM, Marei I, Ding H, Triggle CR. Metformin modulates hyperglycaemia-induced endothelial senescence and apoptosis through SIRT1. Br J Pharmacol 2014 Jan;171(2):523-35.
26. Chen JX, Tuo Q, Liao DF, Zeng H. Inhibition of Protein Tyrosine Phosphatase Improves Angiogenesis via Enhancing Ang-1/Tie-2 Signaling in Diabetes. Exp Diabetes Res 2012;2012:836759.
27. Gomes MB, Negrato CA. Alpha-lipoic acid as a pleiotropic compound with potential therapeutic use in diabetes and other chronic diseases. Diabetology & metabolic syndrome. 2014;6(1):80.
28. Hu P, Lai D, Lu P, Gao J, He H. ERK and Akt signaling pathways are involved in advanced glycation end product-induced autophagy in rat vascular smooth muscle cells. Int J Mol Med 2012 Apr;29(4):613-8.
29. Kim KA, Shin YJ, Akram M, Kim ES, Choi KW, Suh H, et al. High glucose condition induces autophagy in endothelial progenitor cells contributing to angiogenic impairment. Biol Pharm Bull 2014;37(7):1248-52.
30. Schaffer SW, Jong CJ, Mozaffari M. Role of oxidative stress in diabetes-mediated vascular dysfunction: unifying hypothesis of diabetes revisited. Vascul Pharmacol 2012 Nov-Dec;57(5-6):139-49.
31. Aragno M, Mastrocola R, Ghe C, Arnoletti E, Bassino E, Alloatti G, et al. Obestatin induced recovery of myocardial dysfunction in type 1 diabetic rats: underlying mechanisms. Cardiovasc Diabetol. 2012;11:129.
32. Chong ZZ, Maiese K. Mammalian Target of Rapamycin Signaling in Diabetic Cardiovascular Disease. Cardiovasc Diabetol 2012 Apr 30;11(1):45.
33. Das A, Durrant D, Koka S, Salloum FN, Xi L, Kukreja RC. Mammalian Target of Rapamycin (mTOR) Inhibition with Rapamycin Improves Cardiac Function in Type 2 Diabetic Mice: Potential role of attenuated oxidative stress and altered contractile protein expression. J Biol Chem 2014 Feb 14;289(7):4145-60.
34. He C, Zhu H, Li H, Zou MH, Xie Z. Dissociation of Bcl-2-Beclin1 complex by activated AMPK enhances cardiac autophagy and protects against cardiomyocyte apoptosis in diabetes. Diabetes 2013 Apr;62(4):1270-81.
35. Ling S, Birnbaum Y, Nanhwan MK, Thomas B, Bajaj M, Li Y, et al. Dickkopf-1 (DKK1) phosphatase and tensin homolog on chromosome 10 (PTEN) crosstalk via microRNA interference in the diabetic heart. Basic Res Cardiol 2013;108(3):352.
36. Maiese K. Triple play: Promoting neurovascular longevity with nicotinamide, WNT, and erythropoietin in diabetes mellitus. Biomed Pharmacother 2008 April-May;62(4):218-32.
37. Maiese K, Chong ZZ, Shang YC, Hou J. FoxO proteins: cunning concepts and considerations for the cardiovascular system. Clin Sci (Lond). 2009 Feb;116(3):191-203.
38. Portbury AL, Ronnebaum SM, Zungu M, Patterson C, Willis MS. Back to your heart: ubiquitin proteasome system-regulated signal transduction. J Mol Cell Cardiol 2012 Mar;52(3):526-37.
39. Zhang C, Zhang L, Chen S, et al. The prevention of diabetic cardiomyopathy by non-mitogenic acidic fibroblast growth factor is probably mediated by the suppression of oxidative stress and damage. PLoS One. 2013;8(12):e82287.
40. Coca SG, Ismail-Beigi F, Haq N, Krumholz HM, Parikh CR. Role of intensive glucose control in development of renal end points in type 2 diabetes mellitus: systematic review and meta-analysis intensive glucose control in type 2 diabetes. Arch Intern Med 2012 May 28;172(10):761-9.
41. Hao J, Li F, Liu W, et al. Phosphorylation of PRAS40-Thr246 Involves in Renal Lipid Accumulation of Diabetes. J Cell Physiol 2013 Dec 18.
42. Hao J, Zhu L, Li F, Liu Q, Zhao X, Liu S, et al. Phospho-mTOR: A novel target in regulation of renal lipid metabolism abnormality of diabetes. Exp Cell Res. 2013 Aug 15;319(14):2296-306.
43. Perez-Gallardo RV, Noriega-Cisneros R, Esquivel-Gutierrez E, et al. Effects of diabetes on oxidative and nitrosative stress in kidney mitochondria from aged rats. J Bioenerg Biomembr 2014 Nov 26.
44. Caron AZ, He X, Mottawea W, Seifert EL, Jardine K, Dewar-Darch D, et al. The SIRT1 deacetylase protects mice against the symptoms of metabolic syndrome. FASEB J. 2014 Mar;28(3):1306-16.
45. Castano D, Larequi E, Belza I, et al. Cardiotrophin-1 eliminates hepatic steatosis in obese mice by mechanisms involving AMPK activation. J Hepatol 2014 May;60(5):1017-25.
46. Gao Z, Zhang J, Kheterpal I, Kennedy N, Davis RJ, Ye J. Sirtuin 1 (SIRT1) protein degradation in response to persistent c-Jun Nterminal kinase 1 (JNK1) activation contributes to hepatic steatosis in obesity. J Biol Chem 2011 Jun 24;286(25):22227-34.
47. Kousteni S. FoxO1, the transcriptional chief of staff of energy metabolism. Bone. 2012 Feb;50(2):437-43.
48. Li Y, Xu S, Giles A, et al. Hepatic overexpression of SIRT1 in mice attenuates endoplasmic reticulum stress and insulin resistance in the liver. Faseb J. 2011 Feb 14.
49. Singh A, Singh N, Akanksha, Jayendra, Maurya R, Srivastava A. Coagulanolide modulates hepatic glucose metabolism in C57BL/KsJ-db/db mice. Hum Exp Toxicol 2012 Oct;31(10):1056-65.
50. Hamed S, Bennett CL, Demiot C, Ullmann Y, Teot L, Desmouliere A. Erythropoietin, a novel repurposed drug: An innovative treatment for wound healing in patients with diabetes mellitus. Wound Repair and Regeneration: official publication of the Wound Healing Society [and] the European Tissue Repair Society. 2014 Jan-Feb;22(1):23-33.
51. Hao J, Shen W, Tian C, et al. Mitochondrial nutrients improve immune dysfunction in the type 2 diabetic Goto-Kakizaki rats. J Cell Mol Med. 2009 Apr;13(4):701-11.
52. John CM, Ramasamy R, Al Naqeeb G, Dhiab Al-Nuaimi AH, Adam A. Enhanced CD4+CD25+ regulatory T cells with splenic proliferation and protection against oxidative stress by nicotinamide in gestational diabetes. Curr Med Chem 2012 Aug 16.
53. Maiese K, Chong ZZ, Hou J, Shang YC. The vitamin nicotinamide: Translating nutrition into clinical care. Molecules 2009;14(9):3446-85.
54. Maiese K, Chong ZZ, Shang YC, Wang S. Translating cell survival and cell longevity into treatment strategies with SIRT1. Rom J Morphol Embryol 2011;52(4):1173-85.
55. Zhao Z, Huang G, Wang B, Zhong Y. Inhibition of NF-kappaB activation by Pyrrolidine dithiocarbamate partially attenuates hippocampal MMP-9 activation and improves cognitive deficits in streptozotocin-induced diabetic rats. Behav Brain Res 2013 Feb 1;238:44-7.
56. Sonnen JA, Larson EB, Brickell K, Crane PK, Woltjer R, Montine TJ, et al. Different patterns of cerebral injury in dementia with or without diabetes. Arch Neurol 2009 Mar;66(3):315-22.
57. Kapogiannis D, Boxer A, Schwartz JB, et al. Dysfunctionally phosphorylated type 1 insulin receptor substrate in neural-derived blood exosomes of preclinical Alzheimer's disease. FASEB J. 2014 Oct 23.
58. Maiese K, Chong ZZ, Hou J, Shang YC. New strategies for Alzheimer's disease and cognitive impairment. Oxid Med Cell Longev 2009 Nov-Dec;2(5):279-89.
59. Maiese K, Chong ZZ, Li F. Driving cellular plasticity and survival through the signal transduction pathways of metabotropic glutamate receptors. Curr Neurovasc Res 2005 Dec;2(5):425-46.
60. Aksu I, Ates M, Baykara B, Kiray M, Sisman AR, Buyuk E, et al. Anxiety correlates to decreased blood and prefrontal cortex IGF-1 levels in streptozotocin induced diabetes. Neurosci Lett 2012 Dec 7;531(2):176-81.
61. Reagan LP. Diabetes as a chronic metabolic stressor: causes, consequences and clinical complications. Exp Neurol 2012 Jan;233(1):68-78.
62. Busch S, Kannt A, Kolibabka M, Schlotterer A, Wang Q, Lin J, et al. Systemic treatment with erythropoietin protects the neurovascular unit in a rat model of retinal neurodegeneration. PLoS One 2014;9(7):e102013.
63. Fu D, Wu M, Zhang J, Du M, Yang S, Hammad SM, et al. Mechanisms of modified LDL-induced pericyte loss and retinal injury in diabetic retinopathy. Diabetologia. 2012 Nov;55(11):3128-40.
64. Tang L, Zhang Y, Jiang Y, Willard L, Ortiz E, Wark L, et al. Dietary wolfberry ameliorates retinal structure abnormalities in db/db mice at the early stage of diabetes. Exp Biol Med (Maywood). 2011 Sep 1;236(9):1051-63.
65. Barthelmes D, Zhu L, Shen W, Gillies MC, Irhimeh MR. Differential gene expression in Lin-/VEGF-R2+ bone marrowderived endothelial progenitor cells isolated from diabetic mice. Cardiovasc Diabetol 2014;13(1):42.
66. Chong ZZ, Hou J, Shang YC, Wang S, Maiese K. EPO Relies upon Novel Signaling of Wnt1 that Requires Akt1, FoxO3a, GSK-3beta, and beta-Catenin to Foster Vascular Integrity During Experimental Diabetes. Curr Neurovasc Res 2011 May 1;8(2):103-20.
67. Chong ZZ, Shang YC, Maiese K. Vascular injury during elevated glucose can be mitigated by erythropoietin and Wnt signaling. Curr Neurovasc Res 2007 Aug;4(3):194-204.
68. Hou J, Chong ZZ, Shang YC, Maiese K. FoxO3a governs early and late apoptotic endothelial programs during elevated glucose through mitochondrial and caspase signaling. Mol Cell Endocrinol 2010 Mar 4;321(2):194-206.
69. Liu Q, Li J, Cheng R, et al. Nitrosative stress plays an important role in wnt pathway activation in diabetic retinopathy. Antioxid Redox Signal 2013 Apr 1;18(10):1141-53.
70. Wang L, Di L, Noguchi CT. Erythropoietin, a novel versatile player regulating energy metabolism beyond the erythroid system. Int J Biol Sci. 2014;10(8):921-39.
71. Bagul PK, Banerjee SK. Insulin resistance, oxidative stress and cardiovascular complications: role of sirtuins. Curr Pharm Des 2013;19(32):5663-77.
72. Liu J, Li J, Li WJ, Wang CM. The role of uncoupling proteins in diabetes mellitus. J Diabetes Res 2013;2013:585897.
73. Peng Y, Huang S, Cheng B, et al. Mesenchymal stem cells: A revolution in therapeutic strategies of age-related diseases. Ageing Res Rev 2013 Jan;12(1):103-15.
74. Weinberg E, Maymon T, Weinreb M. AGEs induce caspasemediated apoptosis of rat BMSCs via TNFalpha production and oxidative stress. J Mol Endocrinol 2014 Feb;52(1):67-76.
75. Xu YJ, Tappia PS, Neki NS, Dhalla NS. Prevention of diabetesinduced cardiovascular complications upon treatment with antioxidants. Heart failure reviews. 2014 Jan;19(1):113-21.
76. Yang H, Jin X, Kei Lam CW, Yan SK. Oxidative stress and diabetes mellitus. Clin Chem Lab Med 2011 Nov;49(11):1773-82.
77. Chong ZZ, Li F, Maiese K. Oxidative stress in the brain: Novel cellular targets that govern survival during neurodegenerative disease. Prog Neurobiol 2005 Feb;75(3):207-46.
78. Maiese K, Chong ZZ, Hou J, Shang YC. Oxidative stress: Biomarkers and novel therapeutic pathways. Exp Gerontol 2010 Mar;45(3):217-34.
79. Chong ZZ, Li F, Maiese K. Stress in the brain: novel cellular mechanisms of injury linked to Alzheimer's disease. Brain Res Brain Res Rev 2005 Jul;49(1):1-21.
80. Kim S, Kang IH, Nam JB, Cho Y, Chung DY, Kim SH, et al. Ameliorating the Effect of Astragaloside IV on Learning and Memory Deficit after Chronic Cerebral Hypoperfusion in Rats. Molecules 2015;20(2):1904-21.
81. Wright JW, Harding JW. The Brain Hepatocyte Growth Factor/c-Met Receptor System: A New Target for the Treatment of Alzheimer's Disease. J Alzheimers Dis. 2015 Feb 3.
82. Peng S, Zhao S, Yan F, et al. HDAC2 Selectively Regulates FOXO3a-Mediated Gene Transcription during Oxidative Stress-Induced Neuronal Cell Death. J Neurosci. 2015 Jan 21;35(3):1250-9.
83. Fraineau S, Pal CG, 2nd, Allan DS, Brand M. Epigenetic Regulation of Endothelial Cell-mediated Vascular Repair. The FEBS journal. 2014 Dec 24;Dec.
84. Jenwitheesuk A, Nopparat C, Mukda S, Wongchitrat P, Govitrapong P. Melatonin regulates aging and neurodegeneration through energy metabolism, epigenetics, autophagy and circadian rhythm pathways. Int J Mol Sci 2014;15(9):16848-84.
85. Kilic U, Gok O, Bacaksiz A, Izmirli M, Elibol-Can B, Uysal O. SIRT1 Gene Polymorphisms Affect the Protein Expression in Cardiovascular Diseases. PLoS One 2014;9(2):e90428.
86. Maiese K. Epigenetics in the cerebrovascular system: changing the code without altering the sequence. Curr Neurovasc Res 2014 Feb;11(1):1-3.
87. Xin YJ, Yuan B, Yu B, et al. Tet1-mediated DNA demethylation regulates neuronal cell death induced by oxidative stress. Scientific Reports 2015;5:7645.
88. Asaithambi A, Ay M, Jin H, et al. Protein Kinase D1 (PKD1) Phosphorylation Promotes Dopaminergic Neuronal Survival during 6-OHDA-Induced Oxidative Stress. PLoS One 2014;9(5):e96947.
89. Chen C, Xu Y, Song Y. IGF-1 gene-modified muscle-derived stem cells are resistant to oxidative stress via enhanced activation of IGF-1R/PI3K/AKT signaling and secretion of VEGF. Mol Cell Biochem. 2014 Jan;386(1-2):167-75.
90. Palma HE, Wolkmer P, Gallio M, Correa MM, Schmatz R, Thome GR, et al. Oxidative stress parameters in blood, liver, and kidney of diabetic rats treated with curcumin and/or insulin. Mol Cell Biochem 2014 Jan;386(1-2):199-210.
91. Zeldich E, Chen CD, Colvin TA, et al. The neuroprotective effect of Klotho is mediated via regulation of members of the redox system. J Biol Chem 2014 Aug 29;289(35):24700-15.
92. Akasaki Y, Alvarez-Garcia O, Saito M, Carames B, Iwamoto Y, Lotz MK. FOXO transcription factors support oxidative stress resistance in human chondrocytes. Arthritis & rheumatology (Hoboken, NJ). 2014 Sep 3;66(12):3349-58.
93. Aksu U, Yanar K, Terzioglu D, et al. Effect of tempol on redox homeostasis and stress tolerance in mimetically aged drosophila. Arch Insect Biochem Physiol 2014 Jul 18.
94. Bowes Rickman C, Farsiu S, Toth CA, Klingeborn M. Dry agerelated macular degeneration: mechanisms, therapeutic targets, and imaging. Invest Ophthalmol Vis Sci 2013 Dec;54(14):ORSF68-80.
95. Cheng PW, Ho WY, Su YT, et al. Resveratrol Decrease Fructose-Induced Oxidative Stress Mediated by NADPH Oxidase via an AMPK-Dependent Mechanism. Br J Pharmacol. 2014 Feb 18;171(11):2739-50.
96. Guo R, Li W, Liu B, Li S, Zhang B, Xu Y. Resveratrol protects vascular smooth muscle cells against high glucose-induced oxidative stress and cell proliferation in vitro. Med Sci Monitor Basic Res 2014;20:82-92.
97. Maiese K, Chong ZZ, Shang YC, Hou J. A "FOXO" in sight: Targeting Foxo proteins from conception to cancer. Med Res Rev 2009 May;29(3):395-418.
98. Moghaddasi M, Javanmard SH, Reisi P, Tajadini M, Taati M. The effect of regular exercise on antioxidant enzyme activities and lipid peroxidation levels in both hippocampi after occluding one carotid in rat. J Physiol Sci: JPS. 2014 Sep;64(5):325-32.
99. Patel SA, Velingkaar NS, Kondratov RV. Transcriptional Control of Antioxidant Defense by the Circadian Clock. Antioxid Redox Signal 2014 Jan 3;20(18):2997-3006.
100. Turunc Bayrakdar E, Uyanikgil Y, Kanit L, Koylu E, Yalcin A. Nicotinamide treatment reduces the levels of oxidative stress, apoptosis, and PARP-1 activity in Abeta(1-42)-induced rat model of Alzheimer's disease. Free Radic Res 2014 Feb;48(2):146-58.
101. Guo R, Liu B, Wang K, Zhou S, Li W, Xu Y. Resveratrol ameliorates diabetic vascular inflammation and macrophage infiltration in db/db mice by inhibiting the NF-kappaB pathway. Diabetes & Vascular Disease Research: Official J Int Society Diabetes Vasc Disease 2014 Mar;11(2):92-102.
102. Lee Y, Hong Y, Lee SR, Chang KT. Autophagy contributes to retardation of cardiac growth in diabetic rats. Lab Anim Res 2012 Jun;28(2):99-107.
103. Das F, Dey N, Venkatesan B, Kasinath BS, Ghosh-Choudhury N, Choudhury GG. High glucose upregulation of early-onset Parkinson's disease protein DJ-1 integrates the PRAS40/TORC1 axis to mesangial cell hypertrophy. Cell Signal 2011 Aug;23(8):1311-9.
104. Mao XY, Cao DF, Li X, et al. Huperzine A ameliorates cognitive deficits in streptozotocin-induced diabetic rats. Int J Mol Sci 2014;15(5):7667-83.
105. Hou J, Chong ZZ, Shang YC, Maiese K. Early apoptotic vascular signaling is determined by Sirt1 through nuclear shuttling, forkhead trafficking, bad, and mitochondrial caspase activation. Curr Neurovasc Res. 2010 May;7(2):95-112.
106. Ceriello A, dello Russo P, Amstad P, Cerutti P. High glucose induces antioxidant enzymes in human endothelial cells in culture. Evidence linking hyperglycemia and oxidative stress. Diabetes. 1996 Apr;45(4):471-7.
107. Kurban S, Mehmetoglu I, Yerlikaya HF, Gonen S, Erdem S. Effect of chronic regular exercise on serum ischemia-modified albumin levels and oxidative stress in type 2 diabetes mellitus. Endocr Res. 2011;36(3):116-23.
108. Yano M, Hasegawa G, Ishii M, Yamasaki M, Fukui M, Nakamura N, et al. Short-term exposure of high glucose concentration induces generation of reactive oxygen species in endothelial cells: implication for the oxidative stress associated with postprandial hyperglycemia. Redox Rep. 2004;9(2):111-6.
109. Monnier L, Mas E, Ginet C, Michel F, Villon L, Cristol JP, et al. Activation of oxidative stress by acute glucose fluctuations compared with sustained chronic hyperglycemia in patients with type 2 diabetes. JAMA. 2006 Apr 12;295(14):1681-7.
110. Maiese K, Morhan SD, Chong ZZ. Oxidative stress biology and cell injury during type 1 and type 2 diabetes mellitus. Curr Neurovasc Res. 2007 Feb;4(1):63-71.
111. Liu Z, Stanojevic V, Brindamour LJ, Habener JF. GLP1-derived nonapeptide GLP1(28-36)amide protects pancreatic beta-cells from glucolipotoxicity. J Endocrinol. 2012 May;213(2):143-54.
112. Noriega-Cisneros R, Cortes-Rojo C, Manzo-Avalos S, Clemente-Guerrero M, Calderon-Cortes E, Salgado-Garciglia R, et al. Mitochondrial response to oxidative and nitrosative stress in early stages of diabetes. Mitochondrion. 2013 Nov;13(6):835-40.
113. Ribeiro MC, Barbosa NB, de Almeida TM, Parcianello LM, Perottoni J, de Avila DS, et al. High-fat diet and hydrochlorothiazide increase oxidative stress in brain of rats. Cell Biochem Funct. 2009 Oct;27(7):473-8.
114. Rachek LI, Thornley NP, Grishko VI, LeDoux SP, Wilson GL. Protection of INS-1 cells from free fatty acid-induced apoptosis by targeting hOGG1 to mitochondria. Diabetes. 2006 Apr;55(4):1022-8.
115. Kelley DE, He J, Menshikova EV, Ritov VB. Dysfunction of mitochondria in human skeletal muscle in type 2 diabetes. Diabetes. 2002 Oct;51(10):2944-50.
116. Choo HJ, Kim JH, Kwon OB, Lee CS, Mun JY, Han SS, et al. Mitochondria are impaired in the adipocytes of type 2 diabetic mice. Diabetologia. 2006 Apr;49(4):784-91.
117. Zhang Y, Meng N, Lv Z, Li H, Qu Y. The gene polymorphisms of UCP1 but not PPAR gamma and TCF7L2 are associated with diabetic retinopathy in Chinese type 2 diabetes mellitus cases. Acta ophthalmologica. 2014 Oct 1.
118. Criscuolo F, Mozo J, Hurtaud C, Nubel T, Bouillaud F. UCP2, UCP3, avUCP, what do they do when proton transport is not stimulated? Possible relevance to pyruvate and glutamine metabolism. Biochim Biophys Acta. 2006 Sep-Oct;1757(9-10):1284-91.
119. Li B, Nolte LA, Ju JS, Han DH, Coleman T, Holloszy JO, et al. Skeletal muscle respiratory uncoupling prevents diet-induced obesity and insulin resistance in mice. Nat Med. 2000 Oct;6(10):1115-20.
120. Bernal-Mizrachi C, Weng S, Li B, Nolte LA, Feng C, Coleman T, et al. Respiratory uncoupling lowers blood pressure through a leptin-dependent mechanism in genetically obese mice. Arterioscler Thromb Vasc Biol. 2002 Jun 1;22(6):961-8.
121. Zhang CY, Baffy G, Perret P, Krauss S, Peroni O, Grujic D, et al. Uncoupling protein-2 negatively regulates insulin secretion and is a major link between obesity, beta cell dysfunction, and type 2 diabetes. Cell. 2001 Jun 15;105(6):745-55.
122. Huppertz C, Fischer BM, Kim YB, Kotani K, Vidal-Puig A, Slieker LJ, et al. Uncoupling protein 3 (UCP3) stimulates glucose uptake in muscle cells through a phosphoinositide 3-kinasedependent mechanism. J Biol Chem. 2001 Apr 20;276(16):12520-9.
123. MacLellan JD, Gerrits MF, Gowing A, Smith PJ, Wheeler MB, Harper ME. Physiological increases in uncoupling protein 3 augment fatty acid oxidation and decrease reactive oxygen species production without uncoupling respiration in muscle cells. Diabetes. 2005 Aug;54(8):2343-50.
124. Damasceno DC, Sinzato YK, Bueno A, et al. Mild diabetes models and their maternal-fetal repercussions. J Diabetes Res 2013;2013:473575.
125. Maiese K, Chong ZZ, Shang YC, Wang S. Targeting disease through novel pathways of apoptosis and autophagy. Expert Opin Ther Targets 2012 Dec;16(12):1203-14.
126. Yamada E, Singh R. Mapping autophagy on to your metabolic radar. Diabetes. 2012 Feb;61(2):272-80.
127. Maiese K, Chong ZZ, Shang YC. OutFOXOing disease and disability: The therapeutic potential of targeting FoxO proteins. Trends Mol Med 2008 May;14(5):219-27.
128. Maiese K. Taking aim at Alzheimer's disease through the mammalian target of rapamycin. Ann Med 2014 Aug 8;46(8):587-96.
129. Zhao Y, Scott NA, Fynch S, Elkerbout L, Wong WW, Mason KD, et al. Autoreactive T cells induce necrosis and not BCL-2-regulated or death receptor-mediated apoptosis or RIPK3-dependent necroptosis of transplanted islets in a mouse model of type 1 diabetes. Diabetologia 2014 Oct 10.
130. Chong ZZ, Shang YC, Wang S, Maiese K. A Critical Kinase Cascade in Neurological Disorders: PI 3-K, Akt, and mTOR. Future Neurol 2012;7(6):733-48.
131. Fong Y, Lin YC, Wu CY, et al. The antiproliferative and apoptotic effects of sirtinol, a sirtuin inhibitor on human lung cancer cells by modulating Akt/beta-catenin-Foxo3a axis. ScientificWorldJournal 2014;2014:937051.
132. Guo X, Chen Y, Liu Q, et al. Ac-cel, a novel antioxidant, protects against hydrogen peroxide-induced injury in PC12 cells via attenuation of mitochondrial dysfunction. J Mol Neurosci 2013 Jul;50(3):453-61.
133. Kimura R, Okouchi M, Kato T, Imaeda K, Okayama N, Asai K, et al. Epidermal growth factor receptor transactivation is necessary for glucagon-like peptide-1 to protect PC12 cells from apoptosis. Neuroendocrinology. 2013;97(4):300-8.
134. Choi D, Schroer SA, Lu SY, et al. Erythropoietin protects against diabetes through direct effects on pancreatic beta cells. J Exp Med. 2010 Dec 20;207(13):2831-42.
135. Deng X, Cheng J, Zhang Y, Li N, Chen L. Effects of caloric restriction on SIRT1 expression and apoptosis of islet beta cells in type 2 diabetic rats. Acta Diabetol 2009 Oct 30.
136. Miao XY, Gu ZY, Liu P, et al. The human glucagon-like peptide-1 analogue liraglutide regulates pancreatic beta-cell proliferation and apoptosis via an AMPK/mTOR/P70S6K signaling pathway. Peptides. 2013 Jan;39:71-9.
137. Hamed S, Ullmann Y, Egozi D, Daod E, Hellou E, Ashkar M, et al. Fibronectin potentiates topical erythropoietin-induced wound repair in diabetic mice. J Invest Dermatol 2011 Jun;131(6):1365-74.
138. Dang J, Jia R, Tu Y, Xiao S, Ding G. Erythropoietin prevents reactive oxygen species generation and renal tubular cell apoptosis at high glucose level. Biomed Pharmacother 2010 Dec;64(10):681-5.
139. Nakazawa J, Isshiki K, Sugimoto T, et al. Renoprotective effects of asialoerythropoietin in diabetic mice against ischaemiareperfusion-induced acute kidney injury. Nephrology (Carlton). 2010 Feb;15(1):93-101.
140. Toba H, Sawai N, Morishita M, et al. Chronic treatment with recombinant human erythropoietin exerts renoprotective effects beyond hematopoiesis in streptozotocin-induced diabetic rat. Eur J Pharmacol 2009 Jun 10;612(1-3):106-14.
141. Chen W, Sun Y, Liu K, Sun X. Autophagy: A double-edged sword for neuronal survival after cerebral ischemia. Neural Regen Res 2014 Jun 15;9(12):1210-6.
142. Maiese K. Therapeutic targets for cancer: current concepts with PI 3-K, Akt, & mTOR. The Indian journal of medical research. 2013 Feb;137(2):243-6.
143. Lim YM, Lim H, Hur KY, et al. Systemic autophagy insufficiency compromises adaptation to metabolic stress and facilitates progression from obesity to diabetes. Nat Commun 2014;5:4934.
144. Liu Y, Shi S, Gu Z, et al. Impaired autophagic function in rat islets with aging. Age (Dordr). 2013 Jul 28;35(5):1531-44.
145. He C, Bassik MC, Moresi V, et al. Exercise-induced BCL2-regulated autophagy is required for muscle glucose homeostasis. Nature 2012 Jan 26;481(7382):511-5.
146. Nakka VP, Prakash-Babu P, Vemuganti R. Crosstalk Between Endoplasmic Reticulum Stress, Oxidative Stress, and Autophagy: Potential Therapeutic Targets for Acute CNS Injuries. Mol Neurobiol 2014 Dec 9.
147. Wang S, Chong ZZ, Shang YC, Maiese K. WISP1 (CCN4) autoregulates its expression and nuclear trafficking of beta-catenin during oxidant stress with limited effects upon neuronal autophagy. Curr Neurovasc Res. 2012 Apr 4;9(2):89-99.
148. Martino L, Masini M, Novelli M, et al. Palmitate activates autophagy in INS-1E beta-cells and in isolated rat and human pancreatic islets. PLoS One 2012; 7(5): e36188.
149. Lee JH, Lee JH, Jin M, et al. Diet control to achieve euglycemia induces significant loss of heart and liver weight via increased autophagy compared with ad libitum diet in diabetic rats. Exp Mol Med 2014;46:e111.
150. Kibbe C, Chen J, Xu G, Jing G, Shalev A. FOXO1 competes with carbohydrate response element-binding protein (ChREBP) and inhibits thioredoxin-interacting protein (TXNIP) transcription in pancreatic beta cells. J Biol Chem. 2013 Aug 9;288(32):23194-202.
151. Zhao Y, Yu Y, Tian X, et al. Association Study to Evaluate FoxO1 and FoxO3 Gene in CHD in Han Chinese. PLoS One 2014;9(1):e86252.
152. Geldman A, Pallen CJ. Protein tyrosine phosphatases in mast cell signaling. Methods Mol Biol (Clifton, NJ). 2015;1220:269-86.
153. Maiese K. WISP1: Clinical Insights for a Proliferative and Restorative Member of the CCN Family. Curr Neurovasc Res 2014 Sep 12;11(4):378-89.
154. Murahovschi V, Pivovarova O, Ilkavets I, et al. WISP1 is a novel adipokine linked to inflammation in obesity. Diabetes. 2014 Oct 3.
155. Berschneider B, Konigshoff M. WNT1 inducible signaling pathway protein 1 (WISP1): A novel mediator linking development and disease. Int J Biochem Cell Biol 2010 Mar;43(3):306-9.
156. Pennica D, Swanson TA, Welsh JW, et al. WISP genes are members of the connective tissue growth factor family that are upregulated in wnt-1-transformed cells and aberrantly expressed in human colon tumors. Proc Natl Acad Sci USA 1998 Dec 8;95(25):14717-22.
157. Davies SR, Davies ML, Sanders A, Parr C, Torkington J, Jiang WG. Differential expression of the CCN family member WISP-1, WISP-2 and WISP-3 in human colorectal cancer and the prognostic implications. Int J Oncol 2010 May;36(5):1129-36.
158. Berwick DC, Harvey K. The regulation and deregulation of Wnt signaling by PARK genes in health and disease. J Mol Cell Biol. 2014 Feb;6(1):3-12.
159. Chong ZZ, Li F, Maiese K. Cellular demise and inflammatory microglial activation during beta-amyloid toxicity are governed by Wnt1 and canonical signaling pathways. Cell Signal 2007 Jun;19(6):1150-62.
160. Chong ZZ, Shang YC, Hou J, Maiese K. Wnt1 neuroprotection translates into improved neurological function during oxidant stress and cerebral ischemia through AKT1 and mitochondrial apoptotic pathways. Oxid Med Cell Longev 2010 Mar-Apr;3(2):153-65.
161. Jian YC, Wang JJ, Dong S, et al. Wnt-induced secreted protein 1/CCN4 in liver fibrosis both in vitro and in vivo. Clin Lab 2014;60(1):29-35.
162. Klinke DJ, 2nd. Induction of Wnt-inducible signaling protein-1 correlates with invasive breast cancer oncogenesis and reduced type 1 cell-mediated cytotoxic immunity: A retrospective study. PLoS Comput Biol 2014 Jan;10(1):e1003409.
163. Li F, Chong ZZ, Maiese K. Winding through the WNT pathway during cellular development and demise. Histol Histopathol 2006 Jan;21(1):103-24.
164. Loilome W, Bungkanjana P, Techasen A, et al. Activated macrophages promote Wnt/beta-catenin signaling in cholangiocarcinoma cells. Tumour Biol: The Journal of the International Society for Oncodevelopmental Biology and Medicine. 2014 Feb 19.
165. Maiese K, Li F, Chong ZZ, Shang YC. The Wnt signaling pathway: Aging gracefully as a protectionist? Pharmacol Ther 2008 Apr;118(1):58-81.
166. Ortiz-Masia D, Cosin-Roger J, Calatayud S, Hernandez C, Alos R, Hinojosa J, et al. Hypoxic macrophages impair autophagy in epithelial cells through Wnt1: relevance in IBD. Mucosal immunology. 2014 Jul;7(4):929-38.
167. Park HY, Toume K, Arai MA, Sadhu SK, Ahmed F, Ishibashi M. Calotropin: A cardenolide from calotropis gigantea that inhibits Wnt signaling by increasing casein kinase 1alpha in colon cancer cells. Chembiochem 2014 Apr 14;15(6):872-8.
168. Saidak Z, Le Henaff C, Azzi S, Marty C, Marie PJ. Low dose PTH increases osteoblast activity via decreased Mef2c/Sost in senescent osteopenic mice. J Endocrinol 2014 Jul 23.
169. Thorfve A, Lindahl C, Xia W, Igawa K, Lindahl A, Thomsen P, et al. Hydroxyapatite coating affects the Wnt signaling pathway during peri-implant healing in vivo. Acta biomaterialia. 2014 Mar;10(3):1451-62.
170. van den Bosch MH, Blom AB, van Lent PL, van Beuningen HM, Blaney Davidson EN, van der Kraan PM, et al. Canonical Wnt signaling skews TGF-beta signaling in chondrocytes towards signaling via ALK1 and Smad 1/5/8. Cell Signal 2014 May;26(5):951-8.
171. Yeger H, Perbal B. The CCN family of genes: A perspective on CCN biology and therapeutic potential. J Cell Commun Signal 2007 Dec;1(3-4):159-64.
172. Su F, Overholtzer M, Besser D, Levine AJ. WISP-1 attenuates p53-mediated apoptosis in response to DNA damage through activation of the Akt kinase. Genes Dev 2002 Jan 1;16(1):46-57.
173. Venkatesan B, Prabhu SD, Venkatachalam K, et al. WNT1-inducible signaling pathway protein-1 activates diverse cell survival pathways and blocks doxorubicin-induced cardiomyocyte death. Cell Signal 2010 May;22(5):809-20.
174. Wang S, Chong ZZ, Shang YC, Maiese K. WISP1 neuroprotection requires FoxO3a post-translational modulation with autoregulatory control of SIRT1. Curr Neurovasc Res 2013 Nov 12;10(1):54-60.
175. You Z, Saims D, Chen S, et al. Wnt signaling promotes oncogenic transformation by inhibiting c-Myc-induced apoptosis. J Cell Biol. 2002 Apr 29;157(3):429-40.
176. Wang S, Chong ZZ, Shang YC, Maiese K. Wnt1 inducible signaling pathway protein 1 (WISP1) blocks neurodegeneration through phosphoinositide 3 kinase/Akt1 and apoptotic mitochondrial signaling involving Bad, Bax, Bim, and Bcl-xL. Curr Neurovasc Res 2012 Feb;9(1):20-31.
177. Chong ZZ, Li F, Maiese K. Activating Akt and the brain's resources to drive cellular survival and prevent inflammatory injury. Histol Histopathol 2005 Jan;20(1):299-315.
178. Yang M, Zhao X, Liu Y, Tian Y, Ran X, Jiang Y. A role for WNT1-inducible signaling protein-1 in airway remodeling in a rat asthma model. Int Immunopharmacol 2013 Oct;17(2):350-7.
179. Reddy VS, Valente AJ, Delafontaine P, Chandrasekar B. Interleukin-18/WNT1-inducible signaling pathway protein-1 signaling mediates human saphenous vein smooth muscle cell proliferation. J Cell Physiol 2011 Dec;226(12):3303-15.
180. Shang YC, Chong ZZ, Wang S, Maiese K. Tuberous sclerosis protein 2 (TSC2) modulates CCN4 cytoprotection during apoptotic amyloid toxicity in microglia. Curr Neurovasc Res 2013 Feb;10(1):29-38.
181. Bayod S, Menella I, Sanchez-Roige S, et al. Wnt pathway regulation by long-term moderate exercise in rat hippocampus. Brain Res 2014 Jan 16;1543:38-48.
182. Borrell-Pages M, Romero JC, Badimon L. LRP5 negatively regulates differentiation of monocytes through abrogation of Wnt signalling. J Cell Mol Med 2014 Feb;18(2):314-25.
183. Chong ZZ, Li F, Maiese K. Group I Metabotropic Receptor Neuroprotection Requires Akt and Its Substrates that Govern FOXO3a, Bim, and beta-Catenin During Oxidative Stress. Curr Neurovasc Res 2006 May;3(2):107-17.
184. Maiese K. The Many Facets of Cell Injury: Angiogenesis to Autophagy. Curr Neurovasc Res 2012 Apr 19;9(2):1-2.
185. Wei L, Sun C, Lei M, et al. Activation of Wnt/beta-catenin Pathway by Exogenous Wnt1 Protects SH-SY5Y Cells Against 6-Hydroxydopamine Toxicity. J Mol Neurosci 2013 Jan;49(1):105-15.
186. Chong ZZ, Shang YC, Wang S, Maiese K. SIRT1: New avenues of discovery for disorders of oxidative stress. Expert Opin Ther Targets 2012 Feb;16(2):167-78.
187. Chun P. Role of sirtuins in chronic obstructive pulmonary disease. Arch Pharm Res 2014 Oct 11;Oct.
188. De Bonis ML, Ortega S, Blasco MA. SIRT1 Is Necessary for Proficient Telomere Elongation and Genomic Stability of Induced Pluripotent Stem Cells. Stem cell reports. 2014 May 6;2(5):690-706.
189. Oblong JE. The evolving role of the NAD+/nicotinamide metabolome in skin homeostasis, cellular bioenergetics, and aging. DNA Repair (Amst). 2014 Nov;23:59-63.
190. Ou X, Lee MR, Huang X, Messina-Graham S, Broxmeyer HE. SIRT1 positively regulates autophagy and mitochondria function in embryonic stem cells under oxidative stress. Stem Cells 2014 May;32(5):1183-94.
191. Albiero M, Poncina N, Tjwa M, et al. Diabetes causes bone marrow autonomic neuropathy and impairs stem cell mobilization via dysregulated p66Shc and Sirt1. Diabetes 2014 Apr;63(4):1353-65.
192. Wang L, Teng R, Di L, et al. PPARalpha and Sirt1 mediate erythropoietin action in increasing metabolic activity and browning of white adipocytes to protect against obesity and metabolic disorders. Diabetes 2013 Dec;62(12):4122-31.
193. Hou J, Wang S, Shang YC, Chong ZZ, Maiese K. Erythropoietin Employs Cell Longevity Pathways of SIRT1 to Foster Endothelial Vascular Integrity During Oxidant Stress. Curr Neurovasc Res 2011 Aug 1;8(3):220-35.
194. Tanno M, Kuno A, Yano T, Miura T, Hisahara S, Ishikawa S, et al. Induction of manganese superoxide dismutase by nuclear translocation and activation of SIRT1 promotes cell survival in chronic heart failure. J Biol Chem. 2010 Mar 12;285(11):8375-82.
195. Chong ZZ, Shang YC, Wang S, Maiese K. PRAS40 Is an Integral Regulatory Component of Erythropoietin mTOR Signaling and Cytoprotection. PLoS One 2012;7(9):e45456.
196. Shang YC, Chong ZZ, Wang S, Maiese K. WNT1 Inducible Signaling Pathway Protein 1 (WISP1) Targets PRAS40 to Govern beta-Amyloid Apoptotic Injury of Microglia. Curr Neurovasc Res 2012 Aug 6;9(4):239-49.
197. Chong ZZ, Shang YC, Zhang L, Wang S, Maiese K. Mammalian target of rapamycin: hitting the bull's-eye for neurological disorders. Oxid Med Cell Longev 2010 Nov-Dec;3(6):374-91.
198. Kopp C, Hosseini A, Singh SP, et al. Nicotinic Acid Increases Adiponectin Secretion from Differentiated Bovine Preadipocytes through G-Protein Coupled Receptor Signaling. Int J Mol Sci 2014;15(11):21401-18.
199. Maiese K, Chong ZZ, Shang YC, Wang S. mTOR: on target for novel therapeutic strategies in the nervous system. Trends Mol Med. 2013 Jan;19(1):51-60.
200. Martinez de Morentin PB, Martinez-Sanchez N, Roa J, et al. Hypothalamic mTOR: The rookie energy sensor. Curr Mol Med 2014 Jan;14(1):3-21.
201. Maiese K. Driving neural regeneration through the mammalian target of rapamycin. Neural Regen Res 2014 Aug 1;9(15):1413-7.
202. Gwinn DM, Shackelford DB, Egan DF, Mihaylova MM, Mery A, Vasquez DS, et al. AMPK phosphorylation of raptor mediates a metabolic checkpoint. Mol Cell 2008 Apr 25;30(2):214-26.
203. Paiva MA, Rutter-Locher Z, Goncalves LM, P et al. Enhancing AMPK activation during ischemia protects the diabetic heart against reperfusion injury. Am J Physiol Heart Circ Physiol 2011 Jun;300(6):H2123-34.
204. Jessen N, Koh HJ, Folmes CD, et al. Ablation of LKB1 in the heart leads to energy deprivation and impaired cardiac function. Biochim Biophys Acta 2010 Jul-Aug;1802(7-8):593-600.
205. Lai CS, Tsai ML, Badmaev V, Jimenez M, Ho CT, Pan MH. Xanthigen suppresses preadipocyte differentiation and adipogenesis through down-regulation of PPARgamma and C/EBPs and modulation of SIRT-1, AMPK, and FoxO pathways. Journal of agricultural and food chemistry. 2012 Feb 1;60(4):1094-101.
206. Guan FY, Gu J, Li W, et al. Compound K protects pancreatic islet cells against apoptosis through inhibition of the AMPK/JNK pathway in type 2 diabetic mice and in MIN6 beta-cells. Life Sci 2014 Jun 27;107(1-2):42-9.
207. Lough D, Dai H, Yang M, et al. Stimulation of the follicular bulge LGR5+ and LGR6+ stem cells with the gut-derived human alpha defensin 5 results in decreased bacterial presence, enhanced wound healing, and hair growth from tissues devoid of adnexal structures. Plast Reconstr Surg 2013 Nov;132(5):1159-71.
208. Jung DW, Kim WH, Williams DR. Reprogram or reboot: small molecule approaches for the production of induced pluripotent stem cells and direct cell reprogramming. ACS Chem Biol 2014 Jan 17;9(1):80-95.
209. Yang CS, Lopez CG, Rana TM. Discovery of nonsteroidal antiinflammatory drug and anticancer drug enhancing reprogramming and induced pluripotent stem cell generation. Stem Cells 2011 Oct;29(10):1528-36.
210. Heo J, Ahn EK, Jeong HG, et al. Transcriptional characterization of Wnt pathway during sequential hepatic differentiation of human embryonic stem cells and adipose tissue-derived stem cells. Biochem Biophys Res Commun 2013 May 3;434(2):235-40.
211. Lim HW, Lee JE, Shin SJ, et al. Identification of differentially expressed mRNA during pancreas regeneration of rat by mRNA differential display. Biochem Biophys Res Commun 2002 Dec 20;299(5):806-12.
212. Price RM, Tulsyan N, Dermody JJ, Schwalb M, Soteropoulos P, Castronuovo JJ, Jr. Gene expression after crush injury of human saphenous vein: using microarrays to define the transcriptional profile. J Am Coll Surg 2004 Sep;199(3):411-8.
213. Liu H, Dong W, Lin Z, et al. CCN4 regulates vascular smooth muscle cell migration and proliferation. Mol Cells 2013 Aug;36(2):112-8.
214. Du J, Klein JD, Hassounah F, Zhang J, Zhang C, Wang XH. Aging increases CCN1 expression leading to muscle senescence. Am J Physiol Cell Physiol 2014 Jan 1;306(1):C28-36.
215. Marchand A, Atassi F, Gaaya A, et al. The Wnt/beta-catenin pathway is activated during advanced arterial aging in humans. Aging Cell. 2011 Apr;10(2):220-32.
216. Johnson SC, Sangesland M, Kaeberlein M, Rabinovitch PS. Modulating mTOR in aging and health. Interdisciplinary topics in gerontology. 2015;40:107-27.
217. Maiese K. Cutting through the Complexities of mTOR for the Treatment of Stroke. Curr Neurovasc Res 2014 Apr 7;11(2):177-86.
218. Neasta J, Barak S, Hamida SB, Ron D. mTOR complex 1: A key player in neuroadaptations induced by drugs of abuse. J Neurochem 2014 Jul;130(2):172-84.
219. Tang Z, Baykal AT, Gao H, et al. mTor Is a Signaling Hub in Cell Survival: A Mass-Spectrometry-Based Proteomics Investigation. Journal of proteome research. 2014 Apr 14;13(5):2433-44.
220. Chong ZZ, Shang YC, Wang S, Maiese K. Shedding new light on neurodegenerative diseases through the mammalian target of rapamycin. Prog Neurobiol 2012 Aug 15;99(2):128-48.
221. Chong ZZ, Shang YC, Maiese K. Cardiovascular Disease and mTOR Signaling. Trends Cardiovasc Med 2011 Jul;21(5):151-5.
222. Zhou J, Wu J, Zheng F, Jin M, Li H. Glucagon-like peptide-1 analog-mediated protection against cholesterol-induced apoptosis via mammalian target of rapamycin activation in pancreatic betaTC-6 cells. Journal of diabetes. 2014 Jun 9; Sep.
223. Pasini E, Flati V, Paiardi S, Rizzoni D, et al. Intracellular molecular effects of insulin resistance in patients with metabolic syndrome. Cardiovasc Diabetol 2010;9:46.
224. Peng N, Meng N, Wang S, et al. An activator of mTOR inhibits oxLDL-induced autophagy and apoptosis in vascular endothelial cells and restricts atherosclerosis in apolipoprotein E(-/-) mice. Sci Reports 2014;4:5519.
225. Chong ZZ, Kang JQ, Maiese K. Erythropoietin is a novel vascular protectant through activation of Akt1 and mitochondrial modulation of cysteine proteases. Circulation 2002 Dec 3;106(23):2973-9.
226. Maiese K, Chong ZZ, Li F, Shang YC. Erythropoietin: elucidating new cellular targets that broaden therapeutic strategies. Prog Neurobiol 2008 Jun;85(2):194-213.
227. Maiese K, Hou J, Chong ZZ, Shang YC. Erythropoietin, forkhead proteins, and oxidative injury: biomarkers and biology. ScientificWorldJournal 2009;9:1072-104.
228. Wang H, Zhang Q, Wen Q, et al. Proline-rich Akt substrate of 40kDa (PRAS40): A novel downstream target of PI3k/Akt signaling pathway. Cell Signal 2012 Jan;24(1):17-24.
229. Shang YC, Chong ZZ, Wang S, Maiese K. Erythropoietin and Wnt1 Govern Pathways of mTOR, Apaf-1, and XIAP in Inflammatory Microglia. Curr Neurovasc Res 2011 Oct 19;8(4):270-85.
230. Shang YC, Chong ZZ, Wang S, Maiese K. Prevention of betaamyloid degeneration of microglia by erythropoietin depends on Wnt1, the PI 3-K/mTOR pathway, Bad, and Bcl-xL. Aging (Albany NY). 2012 Mar 3;4(3):187-201.
231. Kim J, Jung Y, Sun H, et al. Erythropoietin mediated bone formation is regulated by mTOR signaling. J Cell Biochem. 2012 Jan;113(1):220-8.
232. Wang GB, Ni YL, Zhou XP, Zhang WF. The AKT/mTOR pathway mediates neuronal protective effects of erythropoietin in sepsis. Mol Cell Biochem. 2014 Jan;385(1-2):125-32.
233. Sanghera KP, Mathalone N, Baigi R, et al. The PI3K/Akt/mTOR pathway mediates retinal progenitor cell survival under hypoxic and superoxide stress. Mol Cell Neurosci. 2011 Jun;47(2):145-53.
234. Marfia G, Madaschi L, Marra F, et al. Adult neural precursors isolated from post mortem brain yield mostly neurons: An erythropoietin-dependent process. Neurobiol Dis 2011 Jul;43(1):86-98.
235. Yu T, Li L, Chen T, Liu Z, Liu H, Li Z. Erythropoietin Attenuates Advanced Glycation Endproducts-Induced Toxicity of Schwann Cells In Vitro. Neurochem Res. 2015 Jan 14.
236. Malaguarnera R, Sacco A, Morcavallo A, et al. Metformin inhibits androgen-induced IGF-IR upregulation in prostate cancer cells by disrupting membrane initiated androgren signaling. Endocrinology 2014 Jan 17;155(4):1207-21.
237. Ullah I, Ullah N, Naseer MI, Lee HY, Kim MO. Neuroprotection with metformin and thymoquinone against ethanol-induced apoptotic neurodegeneration in prenatal rat cortical neurons. BMC Neurosci 2012;13:11.
238. Sheng B, Liu J, Li GH. Metformin preconditioning protects Daphnia pulex from lethal hypoxic insult involving AMPK, HIF and mTOR signaling. Comp Biochem Physiol B Biochem Mol Biol 2012 May 4;163(1):51-8.
239. Xie Z, Lau K, Eby B, et al. Improvement of cardiac functions by chronic metformin treatment is associated with enhanced cardiac autophagy in diabetic OVE26 mice. Diabetes 2011 Jun;60(6):1770-8.
240. Jiang T, Yu JT, Zhu XC, et al. Acute metformin preconditioning confers neuroprotection against focal cerebral ischaemia by preactivation of AMPK-dependent autophagy. Br J Pharmacol 2014 Jul;171(13):3146-57.
241. Zhu Z, Yan J, Jiang W, et al. Arctigenin effectively ameliorates memory impairment in Alzheimer's disease model mice targeting both beta-amyloid production and clearance. J Neurosci 2013 Aug 7;33(32):13138-49.
242. Russo E, Andreozzi F, Iuliano R, et al. Early molecular and behavioral response to lipopolysaccharide in the WAG/Rij rat model of absence epilepsy and depressive-like behavior, involves interplay between AMPK, AKT/mTOR pathways and neuroinflammatory cytokine release. Brain Behav Immun 2014 Jul 3;42:157-68.
243. Salminen A, Kaarniranta K, Haapasalo A, Soininen H, Hiltunen M. AMP-activated protein kinase: A potential player in Alzheimer's disease. J Neurochem 2011 Aug;118(4):460-74.
244. Kang S, Chemaly ER, Hajjar RJ, Lebeche D. Resistin promotes cardiac hypertrophy via the AMP-activated protein kinase/mammalian target of rapamycin (AMPK/mTOR) and c-Jun N-terminal kinase/insulin receptor substrate 1 (JNK/IRS1) pathways. J Biol Chem 2011 May 27;286(21):18465-73.
245. Gong H, Pang J, Han Y, et al. Age-dependent tissue expression patterns of Sirt1 in senescence-accelerated mice. Mol Med Reports 2014 Oct 15;10(6):3296-302.
246. Duan W. Sirtuins: from metabolic regulation to brain aging. Front Aging Neurosci 2013;5:36.
247. Srivastava S, Haigis MC. Role of sirtuins and calorie restriction in neuroprotection: implications in Alzheimer's and Parkinson's diseases. Curr Pharm Des 2011;17(31):3418-33.
248. Li F, Chong ZZ, Maiese K. Cell Life Versus Cell Longevity: The Mysteries Surrounding the NAD(+) Precursor Nicotinamide. Curr Med Chem 2006;13(8):883-95.
249. Chen S, Xiao X, Feng X, et al. Resveratrol induces Sirt1-dependent apoptosis in 3T3-L1 preadipocytes by activating AMPK and suppressing AKT activity and survivin expression. J Nutr Biochem 2012 Sep;23(9):1100-12.
250. Chong ZZ, Wang S, Shang YC, Maiese K. Targeting cardiovascular disease with novel SIRT1 pathways. Future Cardiol 2012 Jan;8(1):89-100.
251. Jin X, Chen M, Yi L, Chang H, Zhang T, Wang L, et al. Delphinidin-3-glucoside protects human umbilical vein endothelial cells against oxidized low-density lipoprotein-induced injury by autophagy upregulation via the AMPK/SIRT1 signaling pathway. Mol Nutr Food Res 2014 Oct;58(10):1941-51.
252. Xiong S, Salazar G, Patrushev N, Alexander RW. FoxO1 Mediates an Autofeedback Loop Regulating SIRT1 Expression. J Biol Chem 2011 Feb 18;286(7):5289-99.
253. Canto C, Auwerx J. Caloric restriction, SIRT1 and longevity. Trends Endocrinol Metab 2009 Sep;20(7):325-31.
254. Fulco M, Cen Y, Zhao P, et al. Glucose restriction inhibits skeletal myoblast differentiation by activating SIRT1 through AMPKmediated regulation of Nampt. Dev Cell 2008 May;14(5):661-73.
255. Herranz D, Serrano M. SIRT1: recent lessons from mouse models. Nat Rev Cancer. 2010 Dec;10(12):819-23.
256. Marampon F, Gravina GL, Scarsella L, et al. Angiotensinconverting-enzyme inhibition counteracts angiotensin II-mediated endothelial cell dysfunction by modulating the p38/SirT1 axis. J Hypertens 2013 Oct;31(10):1972-83.
257. Kim DW, Kim YM, Kang SD, Han YM, Pae HO. Effects of Resveratrol and trans-3,5,4'-Trimethoxystilbene on Glutamate-Induced Cytotoxicity, Heme Oxygenase-1, and Sirtuin 1 in HT22 Neuronal Cells. Biomol Ther 2012 May;20(3):306-12.
258. Zhang J, Feng X, Wu J, et al. Neuroprotective effects of resveratrol on damages of mouse cortical neurons induced by beta-amyloid through activation of SIRT1/Akt1 pathway. BioFactors (Oxford, England). 2013 Oct 17;40(2):258-67.
259. Sansone L, Reali V, Pellegrini L, et al. SIRT1 silencing confers neuroprotection through IGF-1 pathway activation. J Cell Physiol 2013 Aug;228(8):1754-61.
260. Wang T, Cui H, Ma N, Jiang Y. Nicotinamide-mediated inhibition of SIRT1 deacetylase is associated with the viability of cancer cells exposed to antitumor agents and apoptosis. Oncol Lett 2013 Aug;6(2):600-4.
261. Du G, Song Y, Zhang T, et al. Simvastatin attenuates TNFalphainduced apoptosis in endothelial progenitor cells via the upregulation of SIRT1. Int J Mol Med 2014 Jul;34(1):177-82.
262. Saini A, Al-Shanti N, Sharples AP, Stewart CE. Sirtuin 1 regulates skeletal myoblast survival and enhances differentiation in the presence of resveratrol. Exp Physiol 2012 Mar;97(3):400-18.
263. Zhao Y, Luo P, Guo Q, et al. Interactions between SIRT1 and MAPK/ERK regulate neuronal apoptosis induced by traumatic brain injury in vitro and in vivo. Exp Neurol 2012 Oct;237(2):489-98.
264. Xiong H, Dai M, Ou Y, et al. SIRT1 expression in the cochlea and auditory cortex of a mouse model of age-related hearing loss. Exp Gerontol 2014 Mar;51:8-14.
265. Chiara B, Ilaria C, Antonietta C, Francesca C, Marco M, Lucia A, et al. SIRT1 Inhibition Affects Angiogenic Properties of Human MSCs. BioMed Res Int 2014;2014:783459.
266. Paschalaki KE, Starke RD, Hu Y, et al. Dysfunction of endothelial progenitor cells from smokers and chronic obstructive pulmonary disease patients due to increased DNA damage and senescence. Stem Cells 2013 Dec;31(12):2813-26.
267. Hong EH, Lee SJ, Kim JS, et al. Ionizing radiation induces cellular senescence of articular chondrocytes via negative regulation of SIRT1 by p38 kinase. J Biol Chem 2010 Jan 8;285(2):1283-95.
268. Kozako T, Aikawa A, Shoji T, et al. High expression of the longevity gene product SIRT1 and apoptosis induction by sirtinol in adult T-cell leukemia cells. Int J Cancer 2012;131(9):2044-55.
269. Balaiya S, Ferguson LR, Chalam KV. Evaluation of sirtuin role in neuroprotection of retinal ganglion cells in hypoxia. Invest Ophthalmol Vis Sci 2012;53(7):4315-22.
270. Dong L, Zhou S, Yang X, Chen Q, He Y, Huang W. Magnolol protects against oxidative stress-mediated neural cell damage by modulating mitochondrial dysfunction and PI3K/Akt signaling. J Mol Neurosci 2013 Jul;50(3):469-81.
271. Qi XF, Li YJ, Chen ZY, Kim SK, Lee KJ, Cai DQ. Involvement of the FoxO3a pathway in the ischemia/reperfusion injury of cardiac microvascular endothelial cells. Exp Mol Pathol 2013;95(2):242-7.
272. Yang Y, Su Y, Wang D, Chen Y, Wu T, Li G, et al. Tanshinol attenuates the deleterious effects of oxidative stress on osteoblastic differentiation via Wnt/FoxO3a signaling. Oxid Med Cell Longev 2013;2013:351895.
273. Min JJ, Huo XL, Xiang LY, et al. Protective effect of Dl-3nbutylphthalide on learning and memory impairment induced by chronic intermittent hypoxia-hypercapnia exposure. Scientific Reports 2014;4:5555.
274. Jang SY, Kang HT, Hwang ES. Nicotinamide-induced mitophagy: event mediated by high NAD+/NADH ratio and SIRT1 protein activation. J Biol Chem 2012;287(23):19304-14.
275. Fang EF, Scheibye-Knudsen M, Brace LE, et al. Defective mitophagy in XPA via PARP-1 hyperactivation and NAD(+)/SIRT1 reduction. Cell 2014 May 8;157(4):882-96.
276. Guo W, Qian L, Zhang J, et al. Sirt1 overexpression in neurons promotes neurite outgrowth and cell survival through inhibition of the mTOR signaling. J Neurosci Res 2011; 89(11):1723-36.
277. Zhang S, Cai G, Fu B, et al. SIRT1 is required for the effects of rapamycin on high glucose-inducing mesangial cells senescence. Mech Ageing Dev. 2012;133(6):387-400.
278. Shi J, Yin N, Xuan LL, Yao CS, Meng AM, Hou Q. Vam3, a derivative of resveratrol, attenuates cigarette smoke-induced autophagy. Acta Pharmacol Sin 2012; 33(7):888-96.
279. Balan V, Miller GS, Kaplun L, et al. Life span extension and neuronal cell protection by Drosophila nicotinamidase. J Biol Chem 2008; 283(41):27810-9.
280. Chong ZZ, Maiese K. Enhanced Tolerance against Early and Late Apoptotic Oxidative Stress in Mammalian Neurons through Nicotinamidase and Sirtuin Mediated Pathways. Curr Neurovasc Res 2008; 5(3):159-70.
281. Sun C, Zhang F, Ge X, et al. SIRT1 improves insulin sensitivity under insulin-resistant conditions by repressing PTP1B. Cell Metab 2007; 6(4):307-19.
282. Wang RH, Kim HS, Xiao C, Xu X, Gavrilova O, Deng CX. Hepatic Sirt1 deficiency in mice impairs mTorc2/Akt signaling and results in hyperglycemia, oxidative damage, and insulin resistance. J Clin Invest 2011 Nov;121(11):4477-90.
283. Frojdo S, Durand C, Molin L, Carey AL, El-Osta A, Kingwell BA, et al. Phosphoinositide 3-kinase as a novel functional target for the regulation of the insulin signaling pathway by SIRT1. Mol Cell Endocrinol 2011; 335(2):166-76.
284. Sundaresan NR, Pillai VB, Wolfgeher D, et al. The deacetylase SIRT1 promotes membrane localization and activation of Akt and PDK1 during tumorigenesis and cardiac hypertrophy. Sci Signal 2011;4(182):ra46.
285. Bordone L, Motta MC, Picard F, et al. Sirt1 regulates insulin secretion by repressing UCP2 in pancreatic beta cells. PLoS Biol 2006; 4(2):e31.
286. Du LL, Chai DM, Zhao LN, et al. AMPK Activation Ameliorates Alzheimer's Disease-Like Pathology and Spatial Memory Impairment in a Streptozotocin-Induced Alzheimer's Disease Model in Rats. J Alzheimers Dis 2014 Aug 11.
287. Czubak P, Bojarska-Junak A, Tabarkiewicz J, Putowski L. A modified method of insulin producing cells' generation from bone marrow-derived mesenchymal stem cells. J Diabetes Res 2014;2014:628591.
288. Schulz TC, Young HY, Agulnick AD, et al. A scalable system for production of functional pancreatic progenitors from human embryonic stem cells. PLoS One 2012; 7(5):e37004.
289. Mazzoccoli G, Tevy MF, Borghesan M, Delle Vergini MR, Vinciguerra M. Caloric restriction and aging stem cells: The stick and the carrot? Exp Gerontol 2014 Feb;50:137-48.
290. Tang AH, Rando TA. Induction of autophagy supports the bioenergetic demands of quiescent muscle stem cell activation. EMBO J 2014; 33(23):2782-97.
291. Chen J, Xavier S, Moskowitz-Kassai E, et al. Cathepsin cleavage of sirtuin 1 in endothelial progenitor cells mediates stress-induced premature senescence. Am J Pathol 2012 Mar;180(3):973-83.
292. Passariello CL, Zini M, Nassi PA, Pignatti C, Stefanelli C. Upregulation of SIRT1 deacetylase in phenylephrine-treated cardiomyoblasts. Biochem Biophys Res Commun 2011; 407(3):512-6.
293. Lemarie CA, Shbat L, Marchesi C, Angulo OJ, Deschenes ME, Blostein MD, et al. Mthfr deficiency induces endothelial progenitor cell senescence via uncoupling of eNOS and downregulation of SIRT1. Am J Physiol Heart Circ Physiol 2011 Mar;300(3):H745-53.
294. Liu X, Chen H, Zhu W, et al. Transplantation of SIRT1-engineered aged mesenchymal stem cells improves cardiac function in a rat myocardial infarction model. J Heart Lung Transplant 2014; 33(10):1083-92.
295. Choudhery MS, Khan M, Mahmood R, et al. Mesenchymal stem cells conditioned with glucose depletion augments their ability to repair-infarcted myocardium. J Cell Mol Med 2012 Oct;16(10):2518-29.
296. Yuen DA, Zhang Y, Thai K, et al. Angiogenic dysfunction in bone marrow-derived early outgrowth cells from diabetic animals is attenuated by SIRT1 activation. Stem Cells Translational Med 2012; 1(12):921-6.
297. Balestrieri ML, Servillo L, Esposito A, et al. Poor glycaemic control in type 2 diabetes patients reduces endothelial progenitor cell number by influencing SIRT1 signalling via platelet-activating factor receptor activation. Diabetologia 2013; 56(1):162-72.
298. Liu DJ, Hammer D, Komlos D, Chen KY, Firestein BL, Liu AY. SIRT1 knockdown promotes neural differentiation and attenuates the heat shock response. J Cell Physiol 2014; 229(9):1224-35.
299. Zhang Y, Wang J, Chen G, Fan D, Deng M. Inhibition of Sirt1 promotes neural progenitors toward motoneuron differentiation from human embryonic stem cells. Biochem Biophys Res Commun. 2011; 404(2):610-4.
300. Saharan S, Jhaveri DJ, Bartlett PF. SIRT1 regulates the neurogenic potential of neural precursors in the adult subventricular zone and hippocampus. J Neurosci Res. 2013 May;91(5):642-59.
301. Aranha MM, Santos DM, Sola S, Steer CJ, Rodrigues CM. miR-34a regulates mouse neural stem cell differentiation. PLoS One. 2011; 6(8):e21396.
302. Lee JS, Park JR, Kwon OS, et al. SIRT1 is required for oncogenic transformation of neural stem cells and for the survival of "cancer cells with neural stemness" in a p53-dependent manner. Neurooncology 2014; 17(1):95-106.
303. Maiese K, Chong ZZ, Shang YC. "Sly as a FOXO": New paths with Forkhead signaling in the brain. Curr Neurovasc Res 2007; 4(4):295-302.
304. Maiese K, Hou J, Chong ZZ, Shang YC. A fork in the path: Developing therapeutic inroads with FoxO proteins. Oxid Med Cell Longev 2009 Jul;2(3):119-29.
305. Yang ZH, Zheng R, Gao Y, Zhang Q, Zhang H. Abnormal gene expression and gene fusion in lung adenocarcinoma with highthroughput RNA sequencing. Cancer Gene Ther 2014; 21(2):74-82.